A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Nanosponge Tunability in Size and Crosslinking Density

7.4K views

DOI:

10.3791/56073

August 4th, 2017

In This Article

Summary

This article describes a process for tuning the size and crosslinking density of covalently crosslinked nanoparticles from linear polyesters containing pendant functionality. By tailoring synthesis parameters (polymer molecular weight, pendant functionality incorporation, and crosslinker equivalents), a desired nanoparticle size and crosslinking density can be achieved for drug delivery applications.

Abstract

We describe a protocol for the synthesis of linear polyesters containing pendant epoxide functionality and their incorporation into a nanosponge with controlled dimensions. This approach begins with synthesis of a functionalized lactone which is key to the pendant functionalization of the resulting polymer. Valerolactone (VL) and allyl-valerolactone (AVL) are then copolymerized using ring-opening polymerization. Post-polymerization modification is then used to install an epoxide moiety on some or all of the pendant allyl groups. Epoxy-amine chemistry is employed to form nanoparticles in a dilute solution of both polymer and small molecule diamine crosslinker based on the desired nanosponge size and crosslinking density. Nanosponge sizes can be characterized by transmission electron microscopy (TEM) imaging to determine the dimension and distribution. This method provides a pathway by which highly tunable polyesters can create tunable nanoparticles, which can be used for small molecule drug encapsulation. Due to the nature of the backbone, these particles are hydrolytically and enzymatically degradable for a controlled release of a wide range of hydrophobic small molecules.

Introduction

Precisely tuning the size and crosslinking density of nanoparticles based on intermolecular crosslinking is of great importance to influence and guide the drug release profile of these nanosystems1. Designing nanosponge tunability, i.e., preparing particles of different network densities, is reliant upon the pendant functionality of the precursor polymer and the equivalents of the hydrophilic crosslinker incorporated. In this approach, the concentration of the precursor and crosslinker in the solvent is important to form nanoparticles of a discrete size rather than a bulk gel. Utilizing quantitative nuclear magnetic resonance spectrosc....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Synthesis and Characterization of AVL

  1. Place a magnetic stir bar inside a 2 neck 500 mL round bottom flask (Flask 1) and seal with an appropriate sized rubber septum and steel wire. Flame dry the flask to remove moisture by purging with nitrogen gas connected through an inlet needle and open outlet needle in the septum, while using a butane flame torch to gently heat the outside of the flask by moving the flame along the surface.
    1. Continue heating the entire flask by running the flame across the surface until moisture clouding the inside of the flask is not seen. Remove the flame and let the flask cool to room temperature whil....

Access restricted. Please log in or start a trial to view this content.

Results

To evaluate the relationship between the synthesis parameters of the nanosponge and its resultant size, the concentration and pendant functionality of each polymer precursor is important. In Figure 1, a successfulsynthetic scheme of nanosponges is carried out under reflux conditions after incorporating both precursor polymer and diamine crosslinker in DCM for 12 h. The concentration of epoxides in the solution is also critical to forming discrete particles. O.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Obtaining reproducible nanosponge sizes is vital in drug delivery applications. Multiple parameters in polymerization and nanosponge synthesis affect the size and crosslink density of the resulting particle. Three important parameters were identified in our analysis: polymer molecular weight, epoxide pendant functionality, and crosslinker equivalents. In order to produce a range of molecular weights and epoxide functionalities for nanosponge synthesis, the stoichiometry of the VL-co-AVL copolymer must be altered.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

LK is thankful for funding from the National Science Foundation Graduate Research Fellowship Program (DGE-1445197) and Vanderbilt University Chemistry Department. LK and EH would like to thank the funding for the Osiris TEM instrument (NSF EPS 1004083).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
2,2'-(Ethylenedioxy)bis(ethylamine)Sigma-Aldrich385506-100ML
3-methyl-1-butanolSigma-Aldrich309435-100MLanhydrous, ≥99%
AcetoneSigma-Aldrich179124-4L
Allyl bromideSigma-AldrichA29585-5G≥99%
Ammonium chlorideFisher ScientificA661-500saturated solution in DI water
Cell culture waterSigma-AldrichW3500-500MLFiltered through 0.45 μm syringe filter
Dichloromethane (DCM)Sigma-Aldrich270997-100MLanhydrous, ≥99%, contains 40 - 150 ppm amylene as stabilizer
Ethyl AcetateFisher ScientificE145SK-4
EZFlow 0.2 μm Syringe FilterFoxx Life Sciences386-2116-OEMHydrophillic PTFE, 13 mm
EZFlow 0.45 μm Syringe FilterFoxx Life Sciences386-3126-OEMHydrophillic PTFE, 25 mm
Fisherbrand Disposable Borosilicate Glass Test Tubes with Plain EndFisher Scientific14-961-31
Fisherbrand Microcentrifuge TubesFisher Scientific14-666-3181.5 mL
Hamilton Microliter Syringe, 100 μLHamilton Company80600Model 710 N SYR, Cemented NDL, 22s ga, 2 in, point style 2
HexamethylphosphoramideSigma-AldrichH11602-100G≥99%, contains ≤1,000 ppm propylene oxide as stabilizer
HexanesFisher ScientificH292-4
Magnesium sulfate anhydrousFisher ScientificM65-500
Meta-chloroperoxybenzoic acidSigma-Aldrich273031-100GPurified to ≥99% by buffer wash
Methanol (MeOH)Sigma-Aldrich322415-100MLanhydrous, ≥99%
N-butyllithium solutionSigma-Aldrich230707-100ML2.5 M in hexanes
N,N-diisopropylethylamineSigma-Aldrich550043-500ML≥99%
Parafilm MSigma-AldrichP7793-1EA
PELCO Pro Reverse (Self-Closing) TweezersTed Pella, Inc.5375-NM
Phosphotungstic acid hydrateAlfa Aesar40116
Q55 SonicatorQsonicaQ55-11055 Watts, 20 kHz
SiliaMetS CysteineSilicycleR80530B-10g
SnakeSkin Dialysis ClipsThermo Scientific68011
SnakeSkin Dialysis Tubing, 10K MWCOThermo Scientific68100
Sodium bicarbonateFisher Scientific5233-500saturated solution in DI water
TEM gridTed Pella, Inc.01822-FUltrathin Carbon Type-A, 400 mesh, Copper, approx. grid hole size: 42 µm
Tetrahydrofuran (THF)Sigma-Aldrich401757-1LAnhydrous, ≥99.9%, inhibitor-free
Tin(II) trifluoromethanesulfonateSigma-Aldrich388122-1G
Vortex-Genie 2Scientific IndustriesSI-0236
Whatman Filter Paper, Grade 1Fisher Scientific09-805HCircles, 185 mm
δ-valerolactoneSigma-Aldrich389579-100MLPurified by vacuum distillation

References

  1. van der Ende, A. E., Sathiyakumar, V., Diaz, R., Hallahan, D. E., Harth, E. Linear release nanoparticle devices for advanced targeted cancer therapies with increased efficacy. Polym Chem. 1 (1), 93(2010).
  2. Sharma, S., Parmar, A., Kori, S., Sandhir, R. PLGA-based nanoparticles: A new paradigm in biomedical applications. Trends Anal Chem. 80, 30-40 (2016).
  3. Cao, L. B., Zeng, S., Zhao, W.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Nanosponge SynthesisPolymer CopolymerizationEpoxide ModificationCrosslinking Density ControlTransmission Electron MicroscopyDialysis PurificationParticle Size AnalysisHydrolytic DegradabilityDrug EncapsulationRing Opening Polymerization